Ramiro Garzon

Ramiro Garzon, MD is Professor of Internal Medicine and Adjunct Professor of Oncological Sciences at the University of Utah. He serves as Chief of the Hematology & Hematologic Malignancies Division and contributes to clinical care at University of Utah Health's Farmington Health Center.

• Research leadership in leukemia molecular mechanisms
• NIH-funded investigator with 12+ years continuous grants
• Active in Huntsman Cancer Institute Research Leadership Council
• Co-Chair of Clinical Innovation and Excellence Committee

His research focuses on AML pathogenesis through microRNA biology, epigenetic regulation, and leukemia stem cell targeting. Key article trends reveal expertise in:

• RNA-based therapeutic strategies
• Bone marrow niche interactions
• Nuclear transport inhibition
• Graft-versus-Host Disease modulation
• miRNA-29/DNMT axis
• Circular RNA functionality

As a clinician-scientist, he maintains active clinical practice while leading laboratory research programs. His 140+ publications demonstrate sustained translational impact across:

• Leukemia genomics
• Epigenetic drug development
• Microenvironmental signaling
• Stem cell targeting approaches
• RNA regulatory networks
• Clinical trial design